Stute Petra, Soukup Jens, Menzel Matthias, Sabatowski Rainer, Grond Stefan
Department of Gynecology, University of Muenster, Muenster, Germany.
J Pain Symptom Manage. 2003 Dec;26(6):1123-31. doi: 10.1016/j.jpainsymman.2003.04.002.
Neuropathic pain is a major problem in the treatment of cancer pain. We performed a retrospective analysis of 213 cancer patients with neuropathic pain treated by a pain service following the World Health Organization guidelines for relief of cancer pain. Of these, 79% presented with nerve compression pain, 16% with nerve injury pain, and 5% with sympathetically-maintained pain. Whereas nerve compression and nerve injury pain were caused most frequently by cancer growth, sympathetically-maintained pain was caused most frequently by cancer treatment. There were no significant differences in the use of analgesics, the mean pain intensity, or the efficacy of analgesic treatment among the three groups. Nerve injury pain and sympathetically-maintained pain were treated more frequently with adjuvant analgesics, especially antidepressants and anticonvulsants. The variety of different neuropathic pain syndromes should be separated in future studies of the efficacy of different treatment approaches.
神经病理性疼痛是癌症疼痛治疗中的一个主要问题。我们按照世界卫生组织缓解癌症疼痛指南,对一家疼痛诊疗机构治疗的213例患有神经病理性疼痛的癌症患者进行了回顾性分析。其中,79%表现为神经压迫性疼痛,16%为神经损伤性疼痛,5%为交感神经维持性疼痛。神经压迫性和神经损伤性疼痛最常见的病因是癌症生长,而交感神经维持性疼痛最常见的病因是癌症治疗。三组在镇痛药使用、平均疼痛强度或镇痛治疗效果方面无显著差异。神经损伤性疼痛和交感神经维持性疼痛更常使用辅助镇痛药治疗,尤其是抗抑郁药和抗惊厥药。在未来不同治疗方法疗效的研究中,应区分各种不同的神经病理性疼痛综合征。